{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T09:44:31Z","timestamp":1725443071034},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.crohns.2010.04.002","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T06:29:31Z","timestamp":1272868171000},"page":"594-598","source":"Crossref","is-referenced-by-count":17,"title":["Long-term efficacy of adalimumab in Paediatric Crohn's disease patients na\u00efve to other anti-TNF therapies"],"prefix":"10.1093","volume":"4","author":[{"given":"J.","family":"Mart\u00edn-de-Carpi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pociello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Varea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2010.04.002_bib1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT 1 randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.crohns.2010.04.002_bib2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/j.gastro.2006.12.003","article-title":"Induction and maintenance infliximab therapy for the treatment of of moderate-to-severe Crohn's disease in children","volume":"132","author":"Hyams","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.04.002_bib3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.dld.2003.12.014","article-title":"Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease","volume":"32","author":"Borrelli","year":"2004","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.crohns.2010.04.002_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cgh.2008.07.010","article-title":"Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study","volume":"6","author":"Thayu","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2010.04.002_bib5","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/j.1572-0241.2000.03263.x","article-title":"Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease","volume":"95","author":"Kugathasan","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.04.002_bib6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/ibd.20045","article-title":"\u201cNew drugs: kids come first\u201d: children should be included in trials of new biological treatments","volume":"13","author":"Cucchiara","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2010.04.002_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2036.2003.01672.x","article-title":"Response to infliximab is related to disease duration in paediatric Crohn's disease","volume":"18","author":"Lionetti","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2010.04.002_bib8","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gut.2006.099978","article-title":"The effectiviness of concomitant immunosuppressive therapy in supressing the formation of antibodies to infliximab in Crohn's disease","volume":"56","author":"Vermeire","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.04.002_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","article-title":"Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.04.002_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.04.002_bib11","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC-II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.04.002_bib12","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ajg.2009.59","article-title":"Comparison of two adalimumab treatment scheduled strategies for moderate-to-severe Crohn's disease:results form the CHARM trial","volume":"104","author":"Colombel","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.04.002_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2036.2010.04304.x","article-title":"Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease","author":"Panaccione","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2010.04.002_bib14","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1053\/j.gastro.2009.07.062","article-title":"Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease","volume":"137","author":"Karmiris","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.04.002_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.mpg.0000169275.86308.b0","article-title":"Adalimumab, a novel anti-tumor necrosis factor-antibody in a child with refractory Crohn's disease","volume":"41","author":"Mian","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2010.04.002_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MPG.0b013e318124504b","article-title":"Adalimumab induces and maintains remission in severe, resistant paediatric Crohn's disease","volume":"46","author":"Hadziselimovic","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2010.04.002_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MPG.0b013e318174e886","article-title":"Safety and efficacy of adalimumab in pediatric patients with Crohn's disease","volume":"47","author":"Wyneski","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2010.04.002_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10620-009-0791-7","article-title":"Adalimumab treatment in children with refractory Crohn's disease","volume":"55","author":"Rosembach","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.crohns.2010.04.002_bib19","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/ibd.20534","article-title":"Short-term response to adalimumab in childhood inflammatory bowel disease","volume":"14","author":"Noe","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2010.04.002_bib20","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1038\/ajg.2009.372","article-title":"Efficacy of adalimumab in moderate-to-severe pediatric Crohn's disease","volume":"104","author":"Viola","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.04.002_bib21","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/ajg.2009.493","article-title":"Retrospective evaluation of the safety and effect of Adalimumab therapy (RESEAT) in pediatric Crohn's disease","volume":"104","author":"Rosh","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.04.002_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T-cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2010.04.002_bib23","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1053\/j.gastro.2008.03.004","article-title":"Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial","volume":"134","author":"Van Assche","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.04.002_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.anpedi.2008.09.014","article-title":"Response to stopping azathioprine in Crohn's patients on combined treatment with infliximab","volume":"70","author":"Mart\u00edn de Carpi","year":"2009","journal-title":"An Pediatr(Barc)"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994610000565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994610000565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/4\/5\/594\/7001521\/4-5-594.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T11:28:03Z","timestamp":1503574083000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2010.04.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1873994610000565"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2010.04.002","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}